US HB4178 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on August 9 2019 - 25% progression, died in committee
Action: 2019-08-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on August 9 2019 - 25% progression, died in committee
Action: 2019-08-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) in relation to discarded amounts (i.e., amounts remaining after administration) of single-dose vial drugs that are covered under Medicare. Manufacturers that fail to comply are subject to civil penalties. The CMS must determine rebate amounts based on payment claims from providers. (Currently, providers may receive payment under Medicare for discarded amounts of single-dose vial drugs through the use of a specific claims modifier.)
Title
REFUND Act of 2019 Recovering Excessive Funds for Unused and Needless Drugs Act of 2019
Sponsors
Rep. Eliot Engel [D-NY] |
History
Date | Chamber | Action |
---|---|---|
2019-08-12 | House | Referred to the Subcommittee on Health. |
2019-08-09 | House | Referred to the Subcommittee on Health. |
2019-08-09 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-08-09 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-08-09 | House | Introduced in House |
Same As/Similar To
SB551 (Same As) 2019-02-25 - Read twice and referred to the Committee on Finance. (text: CR S1439)
Subjects
Accounting and auditing
Civil actions and liability
Government trust funds
Health
Health care costs and insurance
Health information and medical records
Inflation and prices
Medicare
Prescription drugs
Civil actions and liability
Government trust funds
Health
Health care costs and insurance
Health information and medical records
Inflation and prices
Medicare
Prescription drugs
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/4178/all-info |
Text | https://www.congress.gov/116/bills/hr4178/BILLS-116hr4178ih.pdf |